Linda Neuman
Geen lopende functies
Vermogen: 5 195 $ op 30-04-2024
Profiel
Linda Neuman held several positions in the pharmaceutical industry, including Medical Director at Onyx Pharmaceuticals, Senior Medical Director at Puma Biotechnology, and Vice President of Clinical Development at Sunesis Pharmaceuticals and Catalyst Biosciences.
She also served as Chief Medical Officer at Adverum Biotechnologies and Spyre Therapeutics.
Dr. Neuman holds a Doctorate degree from Siu School of Medicine, an undergraduate degree from Southern Illinois University, and an MBA from Indiana Wesleyan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0.00% | 23-02-2023 | 160 ( 0.00% ) | 5 195 $ | 30-04-2024 |
Eerdere bekende functies van Linda Neuman
| Bedrijven | Functie | Einde |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 14-04-2023 |
| CATALYST BIOSCIENCES | Hoofd Techniek/Wetenschap/O&O | 01-04-2021 |
| ADVERUM BIOTECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| PUMA BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Linda Neuman
| Indiana Wesleyan University | Masters Business Admin |
| Southern Illinois University | Undergraduate Degree |
| Siu School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |